Skip to main content
. 2018 Aug 22;9(9):427. doi: 10.3390/genes9090427

Table 2.

Genotype and allelic frequencies of rs3746444, rs2910164, rs12975333, rs2043556, and rs4541843 in BRCA1/2-negative breast cancer cases and controls.

All BC Cases (n = 440) Families with ≥2 BC and/or OC Cases (n = 269) Families with a Single Case, Diagnosis at ≤50 Years of Age (n = 171)
Genotype or Allele Controls (n = 1048) (%) BC Cases (%) p-Value a OR [95% CI] BC Cases (%) p-Value a OR [95% CI] BC Cases (%) p-Value a OR [95% CI]
rs3746444 (Pre-miR-499)
A/A 772 (73.7) 319 (72.5) - 1.0 (Ref) 198 (73.6) - 1.0 (Ref) 121 (70.8) - 1.0 (Ref)
A/G 254 (24.2) 111 (25.2) 0.6 1.0 [0.8–1.3] 64 (23.8) 0.9 0.9 [0.7–1.3] 47 (27.5) 0.3 1.1 [0.8–1.7]
G/G 22 (2.1) 10 (2.3) 0.8 1.1 [0.5–2.3] 7 (2.6) 0.6 1.2 [0.5–2.9] 3 (1.7) 1.0 0.8 [0.2–2.9]
A/G + G/G 276 (26.3) 121 (27.5) 0.6 1.0 [0.8–1.3] 71 (26.4) 1.0 1.0 [0.7–1.3] 50 (29.2) 0.4 1.1 [0.8–1.6]
Allele A 1798 (85.8) 749 (85.1) - 1.0 (Ref) 460 (85.5) - 1.0 (Ref) 289 (84.5) - 1.0 (Ref)
Allele G 298 (14.2) 131 (14.9) 0.6 1.0 [0.8–1.3] 78 (14.5) 0.9 1.0 [0.7–1.3] 53 (15.5) 0.5 1.1 [0.8–1.5]
rs2910164 (Pre-miR-146a)
G/G 561 (53.5) 236 (53.6) - 1.0 (Ref) 149 (55.4) - 1.0 (Ref) 87 (50.9) - 1.0 (Ref)
G/C 410 (39.1) 165 (37.5) 0.7 0.9 [0.7–1.1] 101 (37.5) 0.6 0.9 [0.6–1.2] 64 (37.4) 1.0 1.0 [0.7–1.4]
C/C 77 (7.4) 39 (8.9) 0.3 1.2 [0.7–1.8] 19 (7.1) 0.8 0.9 [0.5–1.5] 20 (11.7) 0.06 1.6 [0.9–2.8]
G/C + C/C 487 (46.5) 204 (46.4) 1.0 0.9 [0.7–1.2] 120 (44.6) 0.6 0.9 [0.7–1.2] 84 (49.1) 0.5 1.1 [0.8–1.5]
Allele G 1532 (73.1) 637 (72.4) - 1.0 (Ref) 399 (74.2) - 1.0 (Ref) 238 (69.6) - 1.0 (Ref)
Allele C 564 (26.9) 243 (27.6) 0.7 1.0 [0.8–1.2] 139 (25.8) 0.6 0.9 [0.7–1.1] 104 (30.4) 0.2 1.1 [0.9–1.5]
rs12975333 (Pre-miR-125a)
G/G 1040 (99.2) 436 (99.1) - 1.0 (ref) 267 (99.3) - 1.0 (ref) 169 (98.8) - 1.0 (ref)
G/T 8 (0.8) 4 (0.9) 0.7 1.1 [0.3–3.9] 2 (0.7) 0.2 1.9 [0.5–6.5] 2 (1.2) 0.6 1.5 [0.3–7.3]
T/T 0 0 - - 0 - - 0 - -
G/T + T/T 8 (0.8) 4 (0.9) 0.7 1.1 [0.3–3.9] 2 (0.7) 0.2 1.9 [0.5–6.5] 2 (1.2) 0.6 1.5 [0.3–7.3]
Allele G 2088 (99.6) 876 (99.5) - 1.0 (ref) 536 (99.6) - 1.0 (ref) 340 (99.4) - 1.0 (ref)
Allele T 8 (0.4) 4 (0.5) 0.7 1.1 [0.3–3.9] 2 (0.4) 0.2 1.9 [0.5–6.5] 2 (0.6) 0.6 1.5 [0.3–7.3]
rs2043556 (miR-605)
T/T 376 (35.9) 208 (47.3) - 1.0 (ref) 128 (47.6) - 1.0 (ref) 80 (46.8) - 1.0 (ref)
T/C 571 (54.5) 182 (41.3) <10−4 0.5 [0.4–0.7] 115 (42.7) 0.0003 0.5 [0.4–0.7] 67 (39.2) 0.0009 0.5 [0.3–0.7]
C/C 101 (9.6) 50 (11.4) 0.6 0.8 [0.6–1.3] 26 (9.7) 0.2 0.7 [0.5 –1.2] 24 (14.0) 0.6 1.1 [0.6–1.8]
T/C + C/C 672 (64.1) 232 (52.7) <10−4 0.6 [0.4–0.7] 141 (52.4) 0.0006 0.6 [0.4–0.8] 91 (53.2) 0.02 0.6 [0.5–0.9]
Allele T 1323 (63.1) 598 (68.0) - 1.0 (ref) 371 (69.0) - 1.0 (ref) 227 (66.4) - 1.0 (ref)
Allele C 773 (36.9) 282 (32.0) 0.01 0.8 [0.6–0.9] 167 (31.0) 0.01 0.7 [0.6–0.9] 115 (33.6) 0.4 0.9 [0.7–1.1]
rs4541843 (Pri-miR-182)
C/C 386 (36.8) 150 (34.1) - 1.0 (Ref) 81 (30.1) - 1.0 (ref) 69 (40.4) - 1.0 Ref
C/T 473 (45.1) 205 (46.6) 0.4 1.1 [0.8–1.4] 127 (47.2) 0.1 1.2 [0.9–1.7] 78 (45.6) 0.6 0.9 [0.6–1.3]
T/T 189 (18.1) 85 (19.3) 0.4 1.5 [0.8–1.5] 61 (22.7) 0.03 1.5 [1.0–2.2] 24 (14.0) 0.1 0.7 [0.4–1.1]
C/T + T/T 662 (63.2) 290 (65.9) 0.3 1.1 [0.8–1.4] 188 (69.9) 0.04 1.3 [1.0–1.8] 102 (59.6) 0.3 0.8 [0.6–1.1]
Allele C 1245 (59.4) 505 (57.4) - 1.0 (Ref) 289 (53.7) - 1.0 (ref) 216 (63.2) - 1.0 (Ref)
Allele T 851 (40.6) 375 (42.6) 0.3 1.0 [0.9–1.2] 249 (46.3) 0.01 1.2 [1.0–1.5] 126 (36.8) 0.2 0.8 [0.6–1.0]

BC—breast cancer; OC—ovarian cancer; OR—odds ratio; CI—confidence interval; Ref—Reference. a Fisher’s exact test. p < 0.05 statistically significant.